Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients-Reference-Cited by-同舟云学术

Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients

Published:2023-03 Issue:3 Volume:24 Page:351-354
ISSN:1389-2010
Container-title:Current Pharmaceutical Biotechnology
language:en
Short-container-title:CPB

Author:

Roviello Giandomenico¹,Fancelli Sara²³^ORCID,Castiglione Francesca⁴,Caliman Enrico²³^ORCID,Francesca Mazzoni⁵,Luca Paglialunga²,Pillozzi Serena⁵,Antonuzzo Lorenzo²³⁵

Affiliation:

1. Department of Health Sciences, Section of Clinical Pharmacology & Oncology, University of Florence, 50134 Florence, Italy

2. Clinical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy

3. Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy

4. Pathological Histology and Molecular Diagnostics Unit, Careggi University Hospital, 50134 Florence, Italy

5. Medical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Reference32 articles.

1. Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 2021,71(3),209-249

2. Rosell R.; Moran T.; Queralt C.; Porta R.; Cardenal F.; Camps C.; Majem M.; Lopez-Vivanco G.; Isla D.; Provencio M.; Insa A.; Massuti B.; Gonzalez-Larriba J.L.; Paz-Ares L.; Bover I.; Garcia-Campelo R.; Moreno M.A.; Catot S.; Rolfo C.; Reguart N.; Palmero R.; Sánchez J.M.; Bastus R.; Mayo C.; Bertran-Alamillo J.; Molina M.A.; Sanchez J.J.; Taron M.; Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009,361(10),958-967

3. Kobayashi Y.; Mitsudomi T.; Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy. Cancer Sci 2016,107(9),1179-1186

4. Lazzari C.; Gregorc V.; Karachaliou N.; Rosell R.; Santarpia M.; Mechanisms of resistance to osimertinib. J Thorac Dis 2020,12(5),2851-2858

5. Santarpia M.; Aguilar A.; Chaib I.; Cardona A.F.; Fancelli S.; Laguia F.; Bracht J.W.P.; Cao P.; Molina-Vila M.A.; Karachaliou N.; Rosell R.; Non-small-cell lung cancer signaling pathways, metabolism, and pd-1/pd-l1 antibodies. Cancers 2020,12(6),12